Modified Dihuangyinzi Treatment Reduced Kidney Marrow Type Clinical Observation Of Senile Dementia

Objective:Modified by observing him for the medical treatment of kidney Dihuangyinzi marrow minus type mild to moderate Alzheimer’s disease clinical efficacy, and to explore subtraction Dihuangyinzi treatment of senile dementia in clinical applications. Provide a viable treatment method for the clinical treatment of kidney marrow minus senile dementia.Methods:Selected from the First Affiliated Hospital of Heilongjiang University of Chinese Medicine yo 2013-2014 outpatient and 60 cases of senile dementia patients in hospital wards, taken randomly divided into treatment group and control group,30 cases in each group. Both groups were receiving basic treatment, the treatment group was treated with piracetam and subtraction Dihuangyinzi soup. The control group was treated with brain rehabilitation medicine, four weeks for a course of treatment, three courses. In Dementia Rating Scale (CDR), mini-mental state table (MMSE), Hasegawa Dementia Scale (HDS), activities of daily living scale capacity (ADL) integral assessment to determine the efficacy of traditional Chinese medicine syndrome integral measurement.Results1. The overall curative effect evaluation:a total of 30 cases of treatment group, the total effective rate was 93.4%; Control group a total of 30 cases, the total effective rate was 70%. Comparison between the two groups have significant difference (P< 0.05).2. MMSE scale score:compared with before treatment, the scores were increased after treatment in both groups, the difference was statistically significant (P< 0.05); Compared with the control group after treatment, the treatment group integral is higher, the difference was statistically significant (P< 0.05).3. HDS dementia rating scale:compared with before treatment, the scores were increased after treatment in both groups, the difference was statistically significant (P< 0.05), compared with the control group, treatment group integral is higher, the difference was statistically significant (P< 0.05).4. ADL scale score:compared with before treatment, the two groups after treatment scores were lower, the difference was statistically significant (P< 0.05); Compared with the control group after treatment, the treatment group points lower (P< 0.05).5. SDSD TCM syndrome integral, compared with before treatment, the two groups after treatment scores were lower (P< 0.05). Compared with the control group after treatment, the treatment group points lower, (P< 0.05).Conclusion:Modified Dihuangyinzi senile dementia can help improve cognitive ability, the ability to improve the activities of daily living, improve clinical medicine medical symptoms.